期刊文献+

抗幽门螺杆菌重组VacA卵黄抗体保护剂的探讨 被引量:1

Research on protectant for immunoglobulin yolk against the vacuolization cytotoxin antigen of Helicobacter pylori
原文传递
导出
摘要 目的比较硫糖铝和多种糖类对抗幽门螺杆菌重组VacA卵黄抗体保护作用,为制备能耐受胃酸和蛋白酶的IgY制剂奠定基础。方法诱导DH5-αvacA-pQE30大量表达VacA蛋白,制备纯化的VacA IgY。在不同酸性的IgY液中加入同浓度各种保护剂,在相同酸性的IgY液中加入不同浓度的各种保护剂,然后加入不同浓度硫糖铝和正常胃内浓度或高浓度的胃蛋白酶,以ELISA法测定试验组IgY的剩余抗体活性(AR)。结果在pH2.0和3.0条件下,各保护剂均能提高IgY抗体活性,且硫糖铝对IgY抗体活性的保护作用优于糖类,在此条件下50%和40%硫糖铝均可完全保持IgY抗体活性。在pH2.0-3.0及正常或高胃蛋白酶浓度下,30%以上硫糖铝均可有效保护IgY的活性。结论低pH下硫糖铝对IgY抗体活性的保护作用优于糖类,且30%以上硫糖铝可增强VacA IgY对胃蛋白酶的耐受能力,是较理想的IgY保护剂。 Objective To compare the protective effect of sucralfate on activity of immunoglobulin yolk(IgY) with that of glucose,glucosan,sucrose,alantin,and sorbitol in order to build a base for the preparation of IgY against gastric acid and pepsin. Methods Protein VacA was expressed in DH5α-vacA-pQE30,and vacA IgY was prepared and purified.Various protectants at the same concentration were added to VacA IgY under different pH levels(2.0-3.0);protectants at different concentrations were added to VacA IgY under the same pH(2.0).Pepsin in normal or abnormal concentrations and sucralfate in various concentrations were added;residual antibody activity of IgY(AR)was determined by ELISA.Results Under pH 2.0 and 3.0,all of the protectant increased the activity of VacA IgY and the AR of IgY containing sucralfate was higher than all of the other carbohydrate protectants.Under pH2.0 and 3.0,50% and 40% sucralfate maintained its activity.Under pH2.0-3.0 and normal or abnormal pepsin concentrations,sucralfate above 30% effectively protected its activity.Conclusion Under a low pH,the protective effect of sucralfate on VacA IgY was better than that of the carbohydrate group.Furthermore,30% or more sucralfate improved the tolerance of VacA IgY against low pepsin,which indicates that sucralfate may be a satisfactory protectant for IgY.
出处 《中国病原生物学杂志》 CSCD 2009年第3期182-186,共5页 Journal of Pathogen Biology
基金 重庆市教委2003年科学研究项目(渝教科2003-7-3) 重庆市科委2005年重庆市第十四批科技项目(CSTC,2005EA5020)
关键词 幽门螺杆菌 卵黄抗体 硫糖铝 抗体活性 保护剂 Helicobacter pylori immunoglobulin yolk sucralfate antibody activity protectant
  • 相关文献

参考文献13

  • 1Lee EN,Sunwoo HH,Menninen K,et al. In vitro studies of chicken egg yolk antibody (IgY) against Salmonella enteritis and Salmonella typhimurium[J]. Poultry Science, 2002,81 : 632-641.
  • 2Sunwoo HH, Lee EN, Menninen K, et al. Growth inhibitory effect of chicken egg yolk antibody (IgY) on Escherichia coli O157:H7 [J]. J Food Sci,2002,67:1486-1494.
  • 3Suzuki H,Nomura S,Masaoka T,et al. Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection[J]. Aliment Pharm Therap, 2004,20 ( Suppl 1 ): 185 - 192.
  • 4Kyong AL, Sung KC, Yoon JL, et al. Acid stability of anti-Helicobacterpylori IgY in aqueous polyol solution[J]. J Biochem Mol Biol,2002,35(5) :488-493.
  • 5Mine Y,Kovacs NJ. Chicken egg yolk antibodies as therapeutics in enteric infections disease[J]. J Med Food,2002,5(3): 159-169.
  • 6陈剑秋,许兰薇,张颖,秦书铭,姚桂森,朱春山.健康成人胃内24小时pH节律的观察[J].天津医药,1997,25(11):667-670. 被引量:8
  • 7毛小琴,杨致邦,张绍兰,田一玲,黄进.幽门螺杆菌重组VacA蛋黄抗体的体外活性[J].世界华人消化杂志,2006,14(8):789-794. 被引量:8
  • 8由昭红,姜中其,王娜,孙建华,吕美儿.抗ETEC F18^+菌毛特异性IgY的稳定性研究[J].中国兽药杂志,2006,40(2):5-8. 被引量:7
  • 9李春晖,郭立君,于洪涛,陈子杨,刘畅,郭凤云,郭凤云,邱爱东,赵伟光,薛凤波,孙世和,王玉琪,张晶.胃蛋白酶对抗狂犬病毒IgY活性的影响[J].中国生物制品学杂志,2002,15(1):45-46. 被引量:20
  • 10Shimizu M, Miwa Y, Hashimoto K, et al. Encapsulation of chicken egg yolk immunoglobulin G (IgY) by liposome[J]. Biosci Biotechnol Biochem, 1993,57(9) : 1445- 1449.

二级参考文献35

  • 1Fu-Bo Xue~1 Yong-Yong Xu~1 Yi Wan~1 Bo-Rong Pan~2 Jun Ren~2 Dai-Ming Fan~3 1 Department of Health Statistics,Department of2 Oncology3 Gastroenterology of XiJing Hospital,the Fourth Military Medical University,Xi’an 710032,Shaanxi Province,China.Association of H.pylori infection with gastric carcinoma:a Meta analysis[J].World Journal of Gastroenterology,2001,7(6):801-804. 被引量:66
  • 2莫剑忠,王承党,王少先,朱翠英,朱志仁,欧阳春,萧树东,袁济民,张德中,江绍基.健康成人餐后胃内食物分布和排空的研究──应用双核素标记试餐及SPECT技术[J].中华消化杂志,1995,15(4):215-217. 被引量:9
  • 3柯美云,蓝宇,王智风,邢进宏.功能性消化不良昼夜胃内pH变化[J].临床消化病杂志,1995,7(3):97-100. 被引量:13
  • 4Zuniga A, Yokoymna H, Rippinger PA, et al. Reduced Intestinal Colonization with F18-positive Enterotoxigenic Escherichia coli in Weaned Pigs Fed Chicken Egg Antibody Against the Fimbriae[J], Immunol Med Microbiol, 1997, 18(3): 153- 161.
  • 5Imberechts H, Deprez P, Van Driessche E, et al. Chicken Egg Yolk Antibodies Against F18ab Fimbriae of Escherichia coli Inhibit Shedding of F18 Positive E. coli by Experimentally Iinfected Pigs[J]. Vet Microbiol, 1997, 54(3) : 329 -341.
  • 6Marquardt RR, Jin LZ, Kim JW, et al. Passive Protective Effect of Egg-yolk Antibodies Against Enterotoxigenic Escherichia coli K88^+ Infection in Neonatal and Early-weaned Piglets [ J ]. FEMS Immunol Med Microbiol, 1999,23(4) : 283 -288.
  • 7Shimizu M, Nagashima H, Hshimoto K, et al. Egg Yolk Antibody (IgY) Stability in Aqueous Solution with High Sugar Concentrations[J]. J Food Sci,1994,59(4) :763 -765.
  • 8Jaradat ZW, Marquardt RR. Studies on the Stability of Chicken IgY in Different Sugars, Complex Carbohydrates and Food Materials [J]. Food Agric Immunol, 2000, 12(4):263 -272.
  • 9Hatta H, Tsuda K, Akachi S, et al. Productivity and Some Properties of Egg Yolk Antibody (IgY) against Human Rotavirus Compared with Rabbit IgG[J].Biosci Biotech Biochem, 1993, 57(3):450-454.
  • 10Davalos- Pantoja L, Ortega-Vinuesa JL, Bastos-Gonzalez D,et al.A Comparative Study Between the Absorption of IgY and IgG on Latex Particles [ J ]. J Biomater Sci Polym Ed, 2000, 11 ( 6 ) :657 - 673.

共引文献35

同被引文献14

  • 1毛小琴,杨致邦,黄伟,张绍兰,田一玲,叶翠莲.幽门螺杆菌重组VacA蛋黄抗体的制备[J].中国生物制品学杂志,2006,19(5):502-504. 被引量:2
  • 2GRANSTROM M, TINDBERG Y, BLENNOW M. Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age[J]. J Clin Microbiol,1997,35(2) :468-470.
  • 3SALIH B A. Helicobacter pylori infection in developing countries: the burden for how long7 [ J ]. Saudi J Gastroenterol, 2009,15 ( 3 ) : 201- 207.
  • 4International Agency for Research on Cancer. Schistosomes,liver flukes and Helicobacter pylori[ M ]. IARC Monograph on the Evaluation of Carcinggenic Risks to Human. 1994, Vo161, Lyon: IARC.
  • 5MINE Y, KOVACS-NOLAN J. Chiken egg yolk antibodies as therapeutics in enteric infections disease[J]. J Med Food,2002,5(3) : 159- 169.
  • 6SUZUKI H,NOMURA S,MASAOKA T,et al. Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection[ J]. Aliment Pharmacol Therap ,2004,20( Suppl 1 ) : 185-192.
  • 7KIYOSHIGE O. Chemistriy of sueralfate[ M ]. New York : Pienum Medical book Company,1995:47-58.
  • 8OHKUSA T, OKAYASU I, MIWA H, et al. Helicobacter pylori infection induces duodenitis and superficial duodenal ulcer in Mongolian gerbils[ J]. Gut,2003,52 (6) :797-803.
  • 9SHIN Ji-hyun, YANG Mier-ha, NAM Seung-woo, et al. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection [ J ]. Clin Diagn Lab Immunol,2002 ;9(5) :1061-1066.
  • 10ISHIMORI A. History of the development of sueralfate [ M ]. New York:Plenum Medical book Company, 1995:35-45.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部